Public Health Authority Leadership: Where Are the Doctors?
- Recent leadership changes adn revised directives for the Swedish Public Health Authority (FOHM) are sparking debate about the agency's future role and capabilities, especially regarding its research capacity.
- The discussion gained momentum following the departure of state epidemiologist magnus Gisslén and the appointment of Olivia Wigzell as Director-General in October 2024.
- Proponents of expanding FOHM's research mandate emphasize the importance of in-house medical expertise for informed decision-making, particularly during public health crises.
“`html
Table of Contents
Recent leadership changes adn revised directives for the Swedish Public Health Authority (FOHM) are sparking debate about the agency’s future role and capabilities, especially regarding its research capacity. Experts argue that bolstering FOHM’s research functions, aligning them with those of the Swedish Medical Products Agency and the Swedish Veterinary Institute (SVA), is crucial for effective public health and pandemic preparedness.
Last updated: September 2, 2024, 02:59:17 CEST
Context: Leadership Transition and New Directives
The discussion gained momentum following the departure of state epidemiologist magnus Gisslén and the appointment of Olivia Wigzell as Director-General in October 2024. Social Minister Jakob Forssmed (KD) described the change as a “fresh start”, accompanied by new instructions intended to align FOHM’s operations with those of other Swedish authorities. This shift in approach has raised concerns about the potential impact on the agency’s scientific expertise and decision-making processes.
The Argument for Enhanced Research Capacity
Proponents of expanding FOHM’s research mandate emphasize the importance of in-house medical expertise for informed decision-making, particularly during public health crises. The experience during the COVID-19 pandemic underscored the value of having strong scientific leadership within the Public Health Authority. A robust research function would allow FOHM to independently assess risks, evaluate interventions, and safeguard scientific integrity.
FOHM is classified as an operational authority, meaning it has the power to implement infection control measures and operate microbiological laboratories. This operational role necessitates a strong foundation in scientific research to ensure that decisions are evidence-based and effective. The analogy is drawn to the Armed Forces, where a lack of military expertise would be unthinkable.
The Swedish Medical Products Agency (Läkemedelsverket) and the Swedish Veterinary Institute (SVA) serve as models for the type of research capacity that advocates believe FOHM should emulate. These agencies conduct extensive research within their respective areas of expertise,informing policy and practise.
Here’s a comparison of the agencies’ core functions:
| Agency | Core Function | research focus |
|---|---|---|
| swedish Public health Authority (FOHM) | Public health protection, infection control, pandemic preparedness | Currently limited; focus on data collection and analysis. |
| Swedish Medical Products Agency (Läkemedelsverket) | Regulation of pharmaceuticals, medical devices | Drug safety, efficacy, pharmacovigilance, clinical trials. |
| swedish Veterinary Institute (
|